According to a new report by Expert Market Research, the global Cell and Gene Therapy Supply Chain Software Market was valued at USD 1.62 Billion in 2025 and is expected to witness robust growth at a CAGR of 11.2% during the forecast period of 2026-2035, reaching an estimated value of USD 4.68 Billion by 2035.
The is driven by the rising adoption of advanced therapies, the increasing prevalence of chronic and genetic disorders, and the growing focus on personalised medicine and patient-specific treatment solutions.
Market growth is further supported by advancements in cloud-based platforms, logistics management systems, and real-time inventory tracking technologies, which enable pharmaceutical and biotechnology companies to streamline complex supply chains while ensuring regulatory compliance.
Obtain a No-Cost Sample Report with Structured TOC
Looking ahead, the Cell and Gene Therapy Supply Chain Software Market is expected to continue expanding across regions such as North America, Europe, and Asia Pacific, supported by government initiatives, increased funding for research and development, and strategic partnerships among leading industry players.
Market Overview
The Cell and Gene Therapy Supply Chain Software Market encompasses a wide range of software solutions designed to manage the complex logistics, patient management, quality control, and regulatory compliance needs of cell and gene therapy manufacturing. Expert Market Research notes that the market has gained traction due to the increasing number of gene therapies entering clinical and commercial stages, which require sophisticated tracking, data management, and inventory systems.
Market Size & Forecast: Expert Market Research Projections
As per Expert Market Research, the Cell and Gene Therapy Supply Chain Software Market was valued at USD 1.62 Billion in 2025. The market is projected to grow at a CAGR of 11.2% from 2026 to 2035, reaching a forecast value of USD 4.68 Billion by 2035.
Macroeconomic & Industry Linkage Analysis
The market is closely linked with the biotechnology and pharmaceutical sectors, where regulatory compliance, patient safety, and supply chain efficiency are critical. Fluctuations in healthcare spending, government funding, and regional adoption rates directly impact market growth.
Moreover, macroeconomic factors such as global trade policies, healthcare infrastructure investments, and technological innovation in IT solutions further influence market dynamics, highlighting the importance of strategic planning and investment in robust software systems.
Key Growth Drivers
- Rising Adoption of Advanced Therapies: Increasing availability and approval of cell and gene therapies necessitate sophisticated supply chain software.
- Technological Advancements: Cloud-based platforms and real-time tracking solutions improve operational efficiency and data integrity.
- Regulatory Compliance: Stringent regulations in cell and gene therapy manufacturing drive demand for compliance-focused software solutions.
- Growing Biotechnology Sector: Expansion of biotech companies and personalized medicine initiatives fuels market growth.
- Investment in Research and Development: Increased funding and partnerships encourage innovation in supply chain management tools.
Market Trends
Expert Market Research highlights a trend toward cloud-based deployment models, offering scalability and remote accessibility for global operations. Additionally, integration of artificial intelligence and data analytics is enhancing predictive management and risk mitigation in supply chains.
Another notable trend is the focus on patient-centric solutions, including improved tracking of patient samples, personalised treatment schedules, and enhanced traceability throughout the supply chain.
Market Challenges & Risk Factors
The market faces challenges such as high implementation costs, complex integration with existing systems, and the need for specialized expertise to manage advanced software solutions.
Additionally, regulatory uncertainties, cybersecurity risks, and supply chain disruptions may pose hurdles to market expansion, requiring continuous adaptation and strategic planning by stakeholders.
Market Opportunities & White Space Areas
Emerging markets, particularly in Asia Pacific and Latin America, present significant opportunities for expansion due to increasing healthcare infrastructure and investment in cell and gene therapies.
Furthermore, innovation in logistics and patient management solutions, combined with AI-driven predictive analytics, offers white space areas for new entrants and established players to differentiate their offerings.
Value Chain & Supply Chain Analysis
The value chain of the Cell and Gene Therapy Supply Chain Software Market spans from software development and integration to end-user deployment in hospitals, clinics, and research institutes. Efficient supply chain management ensures quality control, compliance, and timely delivery of therapies to patients.
Market Segmentation Analysis
By Type
- Enterprise Manufacturing System (EMS)
- Laboratory Information Management System (LIMS)
- Inventory Management System (IMS)
- Quality Management System (QMS)
- Logistics Management System (LMS)
- Patient Management System (PMS)
- Others
By Application
- Manufacturing Component
- Sample Collection and Processing Component
- Logistics Component
- Patient Identification and Treatment Follow-up Component
- Others
By Deployment Type
- On-premises Deployment
- Cloud-based Deployment
By End User
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Biobanks
- Research and Academic Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
| Company | Headquarters | Key Focus Area |
|---|---|---|
| Azenta Life Sciences | USA | Life Sciences Supply Chain Solutions |
| Biocair | UK | Logistics and Temperature-Controlled Solutions |
| BioLife Solutions | USA | Cell and Gene Therapy Storage and Logistics |
| Cryoport Systems, LLC. | USA | Cold Chain Logistics |
| Lonza | Switzerland | Contract Manufacturing and Supply Chain |
| NMDP BioTherapies | USA | Cell Therapy Logistics and Services |
| TraceLink Inc. | USA | Pharmaceutical Supply Chain Software |
| TrakCel | UK | Cell and Gene Therapy Operations Management |
| LabVantage Solutions Inc. | USA | LIMS and Laboratory Software |
Frequently Asked Questions (FAQs)
1. What is the current size of the Cell and Gene Therapy Supply Chain Software Market?
The market was valued at USD 1.62 Billion in 2025.
2. What is the projected CAGR of the Cell and Gene Therapy Supply Chain Software Market?
The market is expected to grow at a CAGR of 11.2% from 2026 to 2035.
3. Which region dominates the Cell and Gene Therapy Supply Chain Software Market?
North America is currently the leading region in the market due to strong infrastructure and adoption of advanced therapies.
<
About Us:
Expert Market Research is a global market intelligence and consulting platform by Claight delivering data-driven insights across commodities, chemicals, energy, and industrial markets. We design our research to support businesses, analysts, investors, and procurement teams in understanding price trends, supply-demand dynamics, competitive landscapes, gaining competitive intelligence, benchmarking best practices, and developing long-term market outlooks.
Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy, consistency, and relevance. Our analysis is widely used not only for strategic planning, market-entry assessments, and sourcing decisions, but also for investment evaluation across international markets. Our strong emphasis on transparency, factual reporting, and regular data updates to reflect real-time market conditions always keeps you ahead of the curve.
Media Contact:
Company Name: Claight Corporation
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com
